Sarcopenia is an independent prognostic factor in male patients with diffuse large B-cell lymphoma-Reference-Cited by-全球学者库

Sarcopenia is an independent prognostic factor in male patients with diffuse large B-cell lymphoma

Published:2015-09-19 Issue:12 Volume:94 Page:2043-2053
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Nakamura Nobuhiko,Hara Takeshi,Shibata Yuhei,Matsumoto Takuro,Nakamura Hiroshi,Ninomiya Soranobu,Kito Yusuke,Kitagawa Junichi,Kanemura Nobuhiro,Goto Naoe,Shiraki Makoto,Miyazaki Tatsuhiko,Takeuchi Tamotsu,Shimizu Masahito,Tsurumi Hisashi

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-015-2499-4.pdf

Reference55 articles.

1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (2008) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC, Lyon

2. Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, Morel P, Van Den Neste E, Salles G, Gaulard P, Reyes F, Lederlin P, Gisselbrecht C (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346(4):235–242. doi: 10.1056/NEJMoa011795

3. Sehn LH, Donaldson J, Chhanabhai M, Fitzgerald C, Gill K, Klasa R, MacPherson N, O’Reilly S, Spinelli JJ, Sutherland J, Wilson KS, Gascoyne RD, Connors JM (2005) Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. J Clin Oncol 23(22):5027–5033. doi: 10.1200/JCO.2005.09.137

4. Pfreundschuh M, Trumper L, Osterborg A, Pettengell R, Trneny M, Imrie K, Ma D, Gill D, Walewski J, Zinzani PL, Stahel R, Kvaloy S, Shpilberg O, Jaeger U, Hansen M, Lehtinen T, Lopez-Guillermo A, Corrado C, Scheliga A, Milpied N, Mendila M, Rashford M, Kuhnt E, Loeffler M, MabThera International Trial G (2006) CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol 7(5):379–391. doi: 10.1016/S1470-2045(06)70664-7

5. The International Non-Hodgkin’s Lymphoma Prognostic Factors Project (1993) A predictive model for aggressive non-Hodgkin’s lymphoma. N Engl J Med 329(14):987–994. doi: 10.1056/NEJM199309303291402

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nutrition and Lifestyle-Related Factors as Predictors of Muscle Atrophy in Hematological Cancer Patients;Nutrients;2024-01-18

2. The pretreatment Controlling Nutritional Status score is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma;Leukemia & Lymphoma;2023-12-20

3. Prevalence and prognostic value of baseline sarcopenia in hematologic malignancies: a systematic review;Frontiers in Oncology;2023-12-14

4. Prevalence and effect on survival of pre-treatment sarcopenia in patients with hematological malignancies: a meta-analysis;Frontiers in Oncology;2023-10-06

5. Role of body composition and metabolic parameters extracted from baseline 18F-FDG PET/CT in patients with diffuse large B-cell lymphoma;Annals of Hematology;2023-08-02